Abstract
Introduction

47
Leishmaniasis represents a series of insect transmitted, blood-borne diseases caused by 48 more than 20 different protozoan parasite species belonging to the genus Leishmania. These paromomycin and miltefosine are now available but these too are far from ideal as they can 61 be expensive and require medical administration, with some having teratogenic and other 62 unwanted toxicity problems (7). Therefore, there is an urgent requirement for new, safer, cost 63 effective anti-leishmanial treatments.
64
Nitroaromatic compounds are used predominantly as broad spectrum antibiotics to treat stimulated renewed interested in this group of agents with calls made for the reinstatement of BamHI/HindIII then cloned into the corresponding sites of the vector pTrcHis-C (Invitrogen)
181
to form the plasmid pTrcHisC-LmNTR.
Enzyme assay.
184
Recombinant HIS-tagged LmNTR was purified as described (45). Type I NTR activity was infected animals could readily differentiate to the promastigote form and be grown in culture.
217
Therefore, it is implicit that luciferase expression has no effect on L. major growth, observed over the range of 625 to 160,000 cells (Fig. 1C) . In the case of amastigotes such a determined from which dose response curves were generated (Fig. 2B) . From these plots, the 236 IC 50 value for nifurtimox was calculated to be 0.58 ± 0.06 μM. When the susceptibility of 237 differentiated THP-1 cells to nifurtimox was determined using resazurin, the IC 50 value was 238 calculated to be >100 μM ( substrates for purified HIS-tagged L. major NTR using NADH as an electron donor (Fig. 3) .
247
Normally, assays involving this parasite enzyme can be readily followed by monitoring the 248 change in absorbance at 340 nm, corresponding to the oxidation of NADH. However, many
249
ANBs undergo a considerable change in absorbance at this particular wavelength. Instead, 250 enzyme activity was assayed by monitoring the change in absorbance at 420 nm which 251 corresponds to the appearance of the hydroxylamine metabolite (46).
252
Of the thirteen compounds screened, most (ten) were metabolised by LmNTR at a rate 253 faster than that noted for nifurtimox. These "active" compounds were related in that they all 254 contain two nitro groups at positions 2-and 4-relative to the 1-aziridinyl ring. In contrast, the 255 three ANBs that contain a single 2-nitro group were deemed "poor" substrates for the parasite 256 enzyme, having negligible activity values.
258
Leishmanicidal activity and mammalian cytotoxicity of aziridinyl nitrobenzamides.
259
To determine whether there was a correlation between LmNTR activity and anti- the L. major forms were assayed for cytotoxicity against differentiated THP-1 cells (Table 2) 275 (Fig. 4) . In all cases, the ANBs screened had no growth inhibitory effect against this 276 mammalian line at concentrations up to 100 μM. The activity of purified recombinant LmNTR was assessed by using various ANBs as substrates (100 μM) at a fixed concentration of NADH (100 μM). Enzyme activity, expressed in nmoles of NADH oxidised per minute per mg LmNTR (nmol.mg -1 min -1 ),, was then calculated using an ε value of 1,220 M -1 cm -1 with the assumption that four molecules of NADH are o idised per molec le of ANB red ced (46) NFX (nif rtimo ) as sed as control For nif rtimo the change in absorbance at 435 nm as oxidised per molecule of ANB reduced (46). NFX (nifurtimox) was used as control. For nifurtimox, the change in absorbance at 435 nm was followed and enzyme activity determined using an ε value of 19,000 mM -1 cm -1 , again assuming that four molecules of NADH were oxidised per molecule of nitrofuran reduced (47). The enzyme activity values are the means of data from three assays ± standard deviations. The ANB group designations as listed in Table 1 are noted. . In all cases, drug treatments were performed in triplicate and the plots shown represent the average growth inhibition obtained at each concentration ± standard deviation. The curves for compounds CB1954, NH6 and NH10 are shown.
